Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al
Case Number:
2:22-cv-00223
Court:
Nature of Suit:
Other Statutes: Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
- American Center for Law & Justice Inc.
- Bustos Law Firm PC
- Covington & Burling
- Debevoise & Plimpton
- Faegre Drinker
- Fillmore Law Firm
- Hogan Lovells
- McCarn & Weir
- Morgan Williamson
- Mullin Hoard
- Perdue Brandon
- Samples Jennings
- Sheppard Mullin
- Shutts & Bowen
- Smith Appellate Law Firm
- Weycer Kaplan
Companies
- American Academy of Family Physicians
- American Medical Association Inc.
- Charlotte Lozier Institute
- Judicial Watch Inc.
Government Agencies
- Commonwealth of Kentucky
- Food and Drug Administration
- State of Indiana
- State of Tennessee
- U.S. Department of Health and Human Services
Sectors & Industries:
-
January 02, 2023
Health Care & Life Sciences Litigation To Watch In 2023
Before the New Year's Eve confetti has even been swept up, lawyers specializing in health care and life sciences already have enough litigation to keep them busy for much of 2023, which is kicking off with federal courts eyeing suits that carry sweeping significance for administrative law, the False Claims Act, drug approvals, the opioid crisis and abortion rights.
-
November 18, 2022
FDA Faces Texas Suit Over Approval Of Abortion Drugs
The U.S. Food and Drug Administration was hit with a lawsuit in Texas federal court Friday from anti-abortion groups that want the agency to be forced to rescind approvals for abortion drugs.
- ← Previous
- 1
- 2
- 3
- Next →